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paGFPRhodopsin is trafﬁcked to the rod outer segment of vertebrate rod cells with high ﬁdelity. When rhodop-
sin transport is disrupted retinal photoreceptors apoptose, resulting in the blinding disease autosomal
dominant retinitis pigmentosa. Herein, we introduce rhodopsin-photoactivatable GFP-1D4 (rhodopsin-
paGFP-1D4) for the purposes of monitoring rhodopsin transport in living cells. Rhodopsin-paGFP-1D4
contains photoactivatable GFP (paGFP) fused to rhodopsin’s C-terminus and the last eight amino acids
of rhodopsin (1D4) appended to the C-terminus of paGFP. The fusion protein binds the chromophore
11-cis retinal and photoisomerizes upon light activation similarly to rhodopsin. It activates the G-protein
transducin with similar kinetics as does rhodopsin. Rhodopsin-paGFP-1D4 localizes to the same compart-
ments, the primary cilium in cultured IMCD cells and the outer segment of rod cells, as rhodopsin in vitro
and in vivo. This enables its use as a model of rhodopsin transport and details the importance of a free
rhodopsin C-terminus in rod cell localization and health.
 2013 Elsevier Ltd. All rights reserved.1. Introduction
G-protein coupled receptors (GPCRs) are a diverse family of
receptors that initiate signaling cascades controlling slow neuro-
transmission, sight, smell, and taste. Due to the diverse roles of
the some 800 known GPCRs in cell signaling processes and disease,
more than one third of all medical drugs target GPCRs (Millar &
Newton, 2010; Overington, Al-Lazikani, & Hopkins, 2006). A major
question that remains is how these receptors are trafﬁcked to their
site of function.
Rod photoreceptors offer an advantageous system to study
GPCR trafﬁcking through the movement of the GPCR rhodopsin
after synthesis in rod cells. Rhodopsin functions in the rod outer
segment (ROS) of these highly polarized neurons by interacting
with photons of light, as well as other signaling proteins involved
in the phototransduction cascade. The ROS is segregated from the
rest of the rod cell by the connecting cilium and can be compared
to the primary ciliary compartment in ciliated cells, though it is
more specialized for phototransduction cascade instead of other
signaling cascades. Rhodopsin is the most abundant protein inthe ROS at a 3 mM or higher concentration, but is almost undetect-
able in either the synaptic terminus, the opposite end of the cell, or
the inner segment, where approximately 107 molecules of the
receptor per cell are synthesized daily in mice (Palczewski,
2012). The fact that rhodopsin is barely detectable in the rod inner
segment could be thought of as an obstacle to monitoring its trans-
port with the commonly used EGFP/FRAP techniques. However,
this obstacle can be overcome with the use of a photoactivatable
GFP (paGFP) instead of EGFP. Photoactivating paGFP instead of
photobleaching EGFP provides a bright spot on a dark background
instead of a dark spot on a bright background.
The role of rhodopsin’s carboxy-terminal domain (C-terminus)
in rhodopsin transport and localization was ﬁrst suggested by
transgenic animal studies. Collectively these studies demonstrate
that mice with transgenes encoding rhodopsin mutants Q344ter
or P347S, and transgenic rats with S334ter rhodopsin are prone
to extensive mislocalization of rhodopsin to the plasma membrane
of the inner segments (Li et al., 1996; Sung et al., 1994). Antibody
labeling for different rhodopsin variants reveals that the mislocal-
ized proteins are mutant rhodopsins, while WT rhodopsin predom-
inantly localizes properly to the ROS. These same mutations cause
autosomal dominant retinitis pigmentosa, degeneration of photo-
receptors that leads to blindness, in human patients (Dryja et al.,
1990, 1991). Recent studies with the hRhoG knock-in mice express-
ing EGFP fused to rhodopsin’s C-terminus show that obstruction of
the C-terminus by EGFP causes recessive retinal degeneration in
homozygous knock-in mice due to malformed disks in the ROS,
Fig. 1. Schematic representation of rhodopsin-paGFP-1D4. Photoactivatable green
ﬂuorescent protein (paGFP) was added to the C-terminus of rhodopsin and the last
eight amino acids were cloned and repeated at the C-terminus of paGFP generating
rhodopsin-paGFP-1D4. The i3 loop (grey circles) binds transducin. Rhodopsin’s 2
palmitoylation sites (horizontal striped circle) help anchor the cytoplasmic tail
while the phosphorylation sites (black circles) peppered along the C-terminus help
initiate inactivation of the protein. The last four amino acids of rhodopsin (vertical
striped circle), the VXPX sorting motif, are responsible for proper rhodopsin
trafﬁcking and are contained within the 1D4 epitope (caliper).
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et al., 2006; Wensel et al., 2005). The hRhoG heterozygous mouse
retinas expressing rhodopsin and rho-EGFP do not degenerate
and rho-EGFP localization appears similar to rhodopsin localiza-
tion, implying rhodopsin helps rho-EGFP enter the ROS thereby
demonstrating the recessive nature of rho-EGFP induced retina
degeneration in mice. Though some rhodopsin-EGFP mislocaliza-
tion can be seen, it is to a lesser degree than is observed in the rho-
dopsin trafﬁcking mutants and is not believed to be the cause of
retinal degeneration in these mice due to the grossly malformed
outer segments.
Photoreceptors do not properly polarize in culture (Saga, Sche-
urer, & Adler, 1996; Stenkamp & Adler, 1993) so immortalized cil-
iated cells have been useful for characterization studies in
dissociated culture. In polarized Madin–Darby Canine Kidney
(MDCK) cells, a multi-ciliated cell line, rhodopsin has been shown
to localize apically, the location where cilia are found in polarized
ciliated cells (Chuang & Sung, 1998). Mouse inner medullary
collecting duct (IMCD) cells are used in ciliary studies because they
contain a single cilium per cell at the apical end of the polarized
cell (Rauchman et al., 1993). In this study, we characterize the
synthetic rhodopsin fusion protein, rhodopsin-paGFP-1D4
(Fig. 1), for use in rhodopsin trafﬁcking studies. The fusion protein
has a photoactivatable green ﬂuorescent protein (paGFP) appended
to the C-terminus of rhodopsin (Pedelacq et al., 2006; Ruta et al.,
2010). To gain more insight on the effects of obstructing the rho-
dopsin C-terminus, rhodopsin-paGFP-1D4 has the last eight amino
acids of rhodopsin added to the C-terminus of paGFP. We report
the ability of rhodopsin-paGFP-1D4 to fold, photobleach, activate
the G-protein transducin and localize to the cilium in IMCD cells
and outer segment of rod cells for use in trafﬁcking studies.2. Material and methods
2.1. Generation of rhodopsin constructs
The pMT3-rhodopsin and pMT3-rhodopsin-EGFP-1D4 plasmids
containing rhodopsin or EGFP fused to rhodopsin with the lasteight amino acids of rhodopsin appended to the C-terminus of
EGFP were obtained from Daniel Oprian (Jin, McKee, & Oprian,
2003). Using a series of QuikChange reactions with oligos from
Invitrogen and Pfu enzyme (Stratagene), pMT3-rhodopsin-EGFP-
1D4 was changed to pMT3-rhodopsin-paGFP-1D4 (Table 1) (Pede-
lacq et al., 2006; Ruta et al., 2010). The cDNAs encoding rhodopsin
and the fusion protein were subcloned into the pcDNA3.1+ vector
(Invitrogen) between the EcoRI and NotI restriction sites for mam-
malian cell transfection purposes and into the pXOP0.8 vector
(courtesy of Orson Moritz) for transgenic Xenopus laevis prepara-
tion. The pXOP0.8 vector contains 800 bp of the Xenopus opsin pro-
moter (XOP) directly before the insertion site (Tam et al., 2006). A
recognition site for the I-SceI meganuclease was inserted at a PciI
site approximately 60 base pairs from the beginning of the XOP re-
gion using cassette mutagenesis as previously described (Gross,
Rao, & Oprian, 2003).
2.2. Tissue culture
COS-7 cells were grown at 37 C, 5% CO2 in DMEM supple-
mented with 100 U/mL/100 lg/mL penicillin/streptomycin, 2 mM
L-glutamine, and 10% FBS. The cells were grown to 95% conﬂuency
on 150 mm petri dishes or on cover slips in twelve well plates and
transfected with the pMT3 constructs using the DEAE-Dextran
method as per (Zeitz et al., 2008). Transfected cells were harvested
72 h post-transfection for maximum protein expression.
IMCD cells were grown at 37 C, 5% CO2 in DMEM supple-
mented 1:1 with Hamm’s F-12, 100 U/mL/100 lg/mL penicillin/
streptomycin, 2 mM L-glutamine, and 10% FBS. Cells were transfec-
ted with either pMT3 or pcDNA3.1+ constructs for transient (high
expression) or stable (low expression) transfections respectively
via electroporation. Transiently transfected cells were grown for
24 h and polarized for an additional 24 h after transfection. Stably
transfected cells were grown for 7 days in DMEM media with
50 ng/mL G418 to select for construct integration. Individual colo-
nies were isolated and immunocytochemistry performed to select
colonies expressing adequate amounts of protein. Cells were polar-
ized on 0.4 lm pore ﬁlters and/or through serum starvation.
2.3. Protein puriﬁcation and spectroscopy
The rhodopsins were puriﬁed from COS-7 cells as previously
published (Jin, McKee, & Oprian, 2003). Brieﬂy, under dim red light
at 4 C, 20 lM 11-cis retinal was added to the cell suspension to
reconstitute the pigments. The cells were solubilized, centrifuged
and the supernatant incubated with 1D4-conjugated Sepharose
4B immunoafﬁnity matrix (Oprian et al., 1987). The beads were
washed free of non-binding proteins and rhodopsin was eluted
via competition using an excess of 1D4 peptide (TETSQVAPA).
Puriﬁed rhodopsins were subjected to UV–Visible (UV–Vis)
spectrophotometry from 700 nm to 250 nm on a Cary-Varian 50
spectrophotometer adapted for dark room use. Data were acquired
and processed using Microsoft Ofﬁce Excel (for PC, versions
11.8313.8221 SP3, 12.0.6504.5000 SP2, and 14.0.6129.5000 (64-
bit)) and Origin (Origin Lab, version 8.5.1). Rhodopsin concentra-
tion was calculated using a rhodopsin extinction coefﬁcient of
42,700 M1 cm1 at 500 nm (Zvyaga et al., 1996).
2.4. Transducin activation
Transducin was puriﬁed from bovine rod outer segments using
DEAE-Cellulose ion exchange column and reactions were as previ-
ously outlined (Sammons & Gross, 2012). Brieﬂy, the ability of the
rhodopsins to catalyze the exchange of [35S] GTPcS for bound GDP
in the G-protein transducin was detected with aid of a ﬁlter-bind-
ing assay. Time points were taken every minute with light
Table 1
Oligonucleotides used to convert EGFP to paGFP.
Primer Sequence Function
GFP T203H forward CCACTACCTGAGCCACCAGT CCGCCCTG Convert amino acid 203 in EGFP from threonine to histidine
GFP T203H reverse CAGGGCGGACTGGTGGCTC AGGTAGTGG Convert amino acid 203 in EGFP from threonine to histidine
GFP LT64/65FS forward CCCTCGTGACCACCTTCAGC
TACGGCGTGCAG
Convert amino acids 64 and 65 in EGFP from leucine and threonine to phenylalanine and
serine
GFP LT64/65FS reverse CTGCACGCCGTAGCTGAAG
GTGGTCACGAGGG
Convert amino acids 64 and 65 in EGFP from leucine and threonine to phenylalanine and
serine
GFP V163A forward CGGCATCAAGGCGAACTTCA AGATCC Convert amino acid 163 in EGFP from valine to alanine
GFP V163A reverse GGATCTTGAAGTTCGCCTTG ATGCCG Convert amino acid 163 in EGFP from valine to alanine
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rhodopsins at a concentration of 5 nM. Reaction mixtures con-
tained 10 mM BTP buffer (pH 6.7) containing 150 mM NaCl,
1 mM MgCl2, 1 mM CaCl2, 1 mM EDTA, 1 mM dithiothreitol, 75
nM transducin and 75 lM GTPc35S (100 lCi/mol). Reactions were
initiated with the addition of [35S] GTPcS in the dark.2.5. Generation of transgenic animals
Transgenic X. laevis were generated using the I-SceI meganuc-
lease method at 18 C as described by Ogino, McConnell, and Gra-
inger (2006) with modiﬁcations. After inducing ovulation with
human chorionic gonadotropin, the frogs were allowed to lay eggs
in egg-laying buffer (ELB) (110 mM NaCl, 2 mM KCl, 0.6 mM Na2-
HPO4, 15 mM Tris–Acetate, pH 7.6, 2 mM NaHCO3, 2.1 mMMgSO4).
X. laevis eggs were collected and washed in 1X Modiﬁed Barth’s
Saline prior to dejellying. The fertilized eggs were injected with
pXOP0.8-rhodopsin-paGFP-1D4 and I-SceI enzyme and allowed to
divide. Embryos dividing to the 4-cell stage were isolated and al-
lowed to develop at 18 C in 0.1 MMR buffer (10 mM NaCl,
200 lM KCl, 100 lM MgSO4, 200 lM CaCl2, 500 lM HEPES pH
7.4). After one week tadpoles were moved to frog water (distilled
water containing 1 g/L Marineland Instant Ocean) for an addi-
tional week. Surviving tadpoles were euthanized with 0.2% tricaine
and their eyes enucleated to determine transgenic protein localiza-
tion. All animal studies were performed in accordance with
approved IACUC protocols.2.6. Protein localization
Transfected cells were ﬁxed in 4% paraformaldahyde in phos-
phate buffered saline (PBS), pH 7.4 for 10 min at RT. The cells were
permeabilized using methanol–acetone (50:50) for 5 min, blocked
in 10% goat serum for 30 min, and probed for rhodopsin and acet-
ylated a-tubulin using 1:2000 rhodopsin B630N antibody against
the rhodopsin amino-terminus (N-terminus) or 1:1000 6-11B-1
antibody against acetylated a-tubulin for 2 h. After washing with
PBS, 1:500 goat-anti-mouse IgG1 secondary conjugated to AF488
or 1:500 goat-anti-mouse IgG2b secondary conjugated to AF568
were used to label B630 and 6-11B-1 respectively. DAPI was used
to label nuclei. Tissue was washed with PBS and mounted using
Life Technologies Prolong Gold anti-fade reagent. Fluorescence
microscopy was then performed using a Zeiss LSM 710 laser scan-
ning or Olympus IX81 spinning disk confocal microscope. COS-7
cells were imaged on the IX81 spinning disk with a 405 nm diode
laser manually moved to photoactivate the paGFP thereby leaving
gaps in the activated paGFP protein.
Eyes from 2-week old transgenic X. laevis were harvested post-
euthanasia, ﬁxed in 4% paraformaldahyde in PBS pH 7.4 overnight
at 4 C, cryoprotected in 30% sucrose in 1X PBS for 2 h at 4 C, fro-
zen in optimal cutting temperature medium (OCT) and sectioned
to 12 lm slices. OCT was washed off the sections with 1X PBS pH
7.4. All tissue was permeabilized using methanol–acetone(50:50) for 5 min, blocked in 10% goat serum for 30 min, and
probed for bovine rhodopsin using 1:1000 rhodopsin 1D4 antibody
against the rhodopsin C-terminus for 2 h. 1:500 goat-anti-mouse
IgG secondary conjugated to AF568 was used to label 1D4. DAPI
was used to label nuclei. Tissue was washed free of the secondary
antibodies and mounted using Prolong Gold Anti-fade Reagent.
Fluorescence microscopy was then performed using an Olympus
IX81 spinning disk confocal microscope to monitor rhodopsin
localization.3. Results
3.1. Fusion protein folding
3.1.1. Spectral analysis of rhodopsin in rho-paGFP-1D4
It was previously established that EGFP tagged rhodopsin is
trafﬁcked apically in mouse rods, however, there are morphologi-
cal defects in the rod cells causing retinal degeneration in homozy-
gous knock-in mice (Gross et al., 2006). Hypothesizing this to be
the result of obstruction of the C-terminal VXPX sorting motif,
we have attached the last eight amino acids of rhodopsin, contain-
ing the VXPXCOOH motif, to the end of GFP and used a photoactivat-
able version of GFP for use in monitoring rhodopsin transport (Jin,
McKee, & Oprian, 2003). To ensure no folding abnormalities were
caused by the fusion, the UV–Vis spectrum of rhodopsin-paGFP-
1D4 was compared to rhodopsin (Fig. 2). Rhodopsin-paGFP-1D4
has an absorption peak at 397 nm generated by paGFP, not present
in rhodopsin (Patterson & Lippincott-Schwartz, 2002). The differ-
ence spectra of rhodopsin and rhodopsin-paGFP-1D4, determined
by subtracting the light spectrum from the dark spectrum, ap-
peared similar with a peak at 500 nm and a trough at 380 nm, indi-
cating that the fusion protein folds correctly, binds 11-cis retinal,
and photobleaches with light.
3.1.2. Ability of paGFP-1D4 to photoactivate
To monitor the ability of paGFP-1D4 to activate in the fusion
protein, we transfected COS-7 cells and looked for the ability of
rho-paGFP-1D4 to photoactivate in the cell (Fig. 3). Pre-activation,
there is minimal paGFP ﬂuorescence, but after activation with
405 nm light, paGFP ﬂuorescence is markedly increased. The ﬂuo-
rescence coincides with rhodopsin labeling, indicating the ﬂuores-
cence is due to photoactivation of the fusion protein.
3.2. Transducin activation
Rhodopsin’s 3rd intracellular (i3) loop binds transducin, rho-
dopsin’s G-protein, and thus plays an important role in activating
transducin (Janz & Farrens, 2004). We performed assays to test
the light-dependent activation of transducin by rhodopsin-
paGFP-1D4 to determine if addition of the 30 kD paGFP affects
transducin activation by inhibition of transducin binding to rho-
dopsin’s i3 loop. Rhodopsin-paGFP-1D4 activates transducin with
comparable kinetics to that of rhodopsin under the same
Fig. 2. Photoconversion of rhodopsin. UV–Visible absorbance spectra were performed on puriﬁed reconstituted rhodopsin (left) and rhodopsin-paGFP-1D4 (right). Spectra
were taken in the dark (dotted line, dark) and after photo-activation (dashed line, light). The difference between the two (solid line, diff) shows photo-conversion of inactive
rhodopsin to active rhodopsin. Photoactivatable-GFP (double line, paGFP) absorbs maximally at 400 nm and can be observed in the rhodopsin-paGFP-1D4 spectra. The
similarity in the difference spectra between rhodopsin and rhodopsin-paGFP-1D4 indicates that rhodopsin-paGFP-1D4 photo-converts properly. Spectra were normalized to
the 500 nm absorbance peak of dark rhodopsin.
Fig. 3. Photoactivation of paGFP in COS-7 cells. COS-7 cells were transfected with pMT3-rho-paGFP-1D4 and immunolabelled for rhodopsin. Minimal paGFP ﬂuorescence was
observed prior to photoactivation (A and B, green). However, after paGFP was photoactivated using 405 nm, paGFP ﬂuorescence observed (C and D, green). The change in
ﬂuorescence of paGFP indicates it ability to be photoactivated. Rhodopsin labeling is overlaid to show the photoactivated protein is rho-paGFP-1D4 (B and D, red). DAPI, blue;
scale bar, 50 lm.
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imally, but after light exposure, there is a marked uptake of [35S]
GTPcS, an indicator that the active rhodopsin fusion protein acti-
vates transducin despite the presence of the photoactivatable
GFP-1D4 moiety.
3.3. Rhodopsin localization
As the paGFP-1D4 contains the VXPX sorting motif known to
target proteins to the cilium instead of to the plasma membrane,
we aimed to determine rhodopsin’s localization within polarized
monociliated mouse IMCD cells as well as in transgenic X. laevis
(Concepcion, Mendez, & Chen, 2002; Tam et al., 2000). We ﬁrst ex-
pressed rhodopsin and rhodopsin-paGFP-1D4 transiently at high
expression levels to mimic the high expression seen in rod cells.
Rhodopsin-paGFP-1D4 localizes to the apical end of IMCD cells
similarly to rhodopsin (Fig. 5A–F). Two possibilities exist for these
proteins localizing to the apical end of the cells instead of solely tothe cilium. The ﬁrst is that there such a high quantity of rhodopsin
being expressed that it overﬂows the cilium into the apical end of
the cell as it is trafﬁcked to the cilium. The second possibility is
that the trafﬁcking machinery is overloaded and a large portion
of the protein is mislocalized to the apical end of the cell. In either
case, reducing the amount of rhodopsin being expressed would re-
duce the amount of rhodopsin outside the cilium if properly local-
ized. As such, we generated IMCD cells stably expressing rhodopsin
or rhodopsin-paGFP-1D4, induced polarization, and monitored for
protein localization. We observed that when expressed at lower
quantities both rhodopsin and rhodopsin-paGFP-1D4 localized so-
lely to the cilium of these cells indicating that at least one of the
VXPX sorting motifs was conformationally available for ciliary
transport in the fusion protein (Fig. 5G–L).
We generated transgenic X. laevis expressing rhodopsin-paGFP-
1D4 under the Xenopus opsin promoter to determine the
localization of the synthetic protein in its natural environment.
Similar to rhodopsin, rhodopsin-paGFP-1D4 localizes to the ROS
Fig. 4. Rhodopsin-paGFP-1D4 activates transducin. Assay testing for transducin
activation. Transducin activation by rhodopsin (grey diamonds) or rhodopsin-
paGFP-1D4 (black squares) was performed. Six time points were taken pre-
rhodopsin activation (ﬁlled markers), exposed to bright white light (hv), and six
more time points taken post-rhodopsin activation (unﬁlled markers). Rhodopsin-
paGFP-1D4 activates transducin with similar kinetic rates as rhodopsin with no
signiﬁcant difference between the maximum activation rates.
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degeneration or mislocalization in these transgenic animals
(n = 15).4. Discussion
We have generated photoactivatable GFP fused to rhodopsin to
monitor rhodopsin movement, a key aspect yet to be explained
with GPCRs. To include a C-terminal rhodopsin sorting motif, we
have attached a repeat of the last eight amino acids of rhodopsin
to the C-terminus of paGFP generating rhodopsin-paGFP-1D4. WeFig. 5. Rhodopsin localization in polarized IMCD cells. IMCD cells expressing high or l
respectively, were probed with acetylated a-tubulin (red) to label the cilium, imaged
localization. Rhodopsin was also probed with the rhodopsin N-terminal antibody B6-3
nuclei were labeled with DAPI (blue). Rhodopsin and rhodopsin-paGFP-1D4 localized to
transiently transfected cells and solely to the cilium in stably transfected cells (orange).have shown that fusion of paGFP-1D4 to rhodopsin’s C-terminus
does not inhibit rhodopsin activation and that the difference spec-
trum of rhodopsin-paGFP-1D4 looks similar to the rhodopsin dif-
ference spectrum. We also showed that the protein functions
correctly in its activation of transducin, signifying no signiﬁcant
difference in function despite the addition of a 30 kD protein to
rhodopsin’s C-terminus.
We next sought to identify the cellular localization of the ﬂuo-
rescent fusion protein in polarized cells and showed that the pro-
tein localizes correctly to the cilium of IMCD cells. This answered
a major question of whether the fusion protein could be properly
transported to the organelle without the help of endogenously ex-
pressed rhodopsin; that the VXPX sorting motif is still functional in
targeting the protein to the cilium in vitro. However, rod cells have
a specialized ciliary organelle, the rod outer segment. In rod cells,
the added step of inserting rhodopsin into disks is present and it
has been shown that rho-EGFP cannot properly perform this task
without the help of rhodopsin even though the majority of rho-
EGFP localize apically (toward the cilium) in homozygous retinas
(Wensel et al., 2005). To monitor the localization of the fusion pro-
tein in vivo, we prepared transgenic X. laevis. Rhodopsin-paGFP-
1D4 localized correctly to the ROS in the transgenic rods similar
to Jin, McKee, and Oprian (2003). A caveat to using dissociated cul-
ture is that the protein is not in its native environment and a caveat
to using transgenic animals is the presence of endogenous rhodop-
sin possibly helping transport. However, combined, these data sug-
gest that in its native environment without the presence of
endogenous rhodopsin, the fusion protein should localize similarly
to rhodopsin. With the addition of the VXPXCOOH sorting motif to
the fusion protein’s C-terminus, the rhodopsin-paGFP-1D4 may
also rescue the abnormal disk and morphologies phenotype ob-
served in the hRhoG knock-in mouse (Gross et al., 2006).
Instead of using a constitutively ﬂuorescing protein fused to
rhodopsin to monitor trafﬁcking, using a photoactivatable version
of the ﬂuorophore enables us to monitor the presence of a brightow amounts of rhodopsin (A–C and G–I) or rhodopsin-paGFP-1D4 (D–F and J–L),
with confocal microscopy and reconstructed in the X–Z plane to monitor ciliary
0N (green) while paGFP on rhodopsin-paGFP-1D4 was photoactivated (green). All
the apical end of the polarized cells, partially co-localizing with the cilium in the
Scale bar, 10 lm.
Fig. 6. Localization of rhodopsin-paGFP-1D4 to the outer segments of transgenic Xenopus laevis at 2 weeks of age. Retinal sections are shown with endogenous rhodopsin (A,
green) and rhodopsin paGFP-1D4 localization (B–D). The paGFP from rhodopsin-paGFP-1D4 transgenic X. laevis retinas (B, green) ﬂuoresces in the ROS. The rhodopsin-paGFP-
1D4 probe shows labeling of rhodopsin-paGFP-1D4 in the ROS (C, red) and the merged image (D, orange) indicates rhodopsin-paGFP-1D4 localizes to the OS in these
photoreceptors. Nuclei, blue. OS, rod outer segment; IS, rod inner segment; ONL, outer nuclear layer; INL, inner nuclear layer. Scale bar, 20 lm.
48 J.D. Sammons, A.K. Gross / Vision Research 93 (2013) 43–48green ﬂuorescent spot on a dark background after photoactivation,
thereby improving the optical ability of photodetection. Instead of
trying to detect a dark spot in a bright green background, as with
FRAP studies on rhodopsin-EGFP (Trivedi et al., 2012) or color
change upon activation (Lodowski et al., 2013), the rho-paGFP-
1D4 transgenic animals are more easily detectible and thereby
may improve spatial kinetic measurements in a living retina. By
using a photoactivatable GFP instead of constitutively active GFP,
we do not limit ourselves to monitoring only the region that we
photobleached. Additionally, the photo-switchable ﬂuorescent
protein must use two channels to monitor ﬂuorescent changes in
the entire cell. Here, a single channel can be used to monitor ﬂuo-
rescent changes inside and outside of the photoactivated region
thereby providing a more simple and comprehensive method of
monitoring rhodopsin and GPCR transport.
In summary, we have generated a rhodopsin-paGFP-1D4 fusion
to be used as a tool to monitor rhodopsin transport. We have
shown that it functions and localizes similarly to rhodopsin
in vitro and in vivo and propose its use for trafﬁcking studies.
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